News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
775,735 Results
Type
Article (74904)
Company Profile (273)
Press Release (700533)
Multimedia
Podcasts (173)
Webinars (32)
Section
Business (200192)
Career Advice (3116)
Deals (36281)
Drug Delivery (149)
Drug Development (88435)
Employer Resources (186)
FDA (16982)
Job Trends (15895)
News (350930)
Policy (34152)
Tag
2027 BioMidwest Elite (1)
2027 Biotech Bay Standard (1)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (3)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (3024)
Academic (2)
Accelerated approval (43)
Adcomms (36)
Allergies (173)
Alliances (51523)
ALS (206)
Alzheimer's disease (1876)
Antibody-drug conjugate (ADC) (404)
Approvals (17241)
Artificial intelligence (687)
Autoimmune disease (246)
Automation (53)
Bankruptcy (337)
Best Places to Work (12210)
BIOSECURE Act (21)
Biosimilars (211)
Biotechnology (180)
Bladder cancer (186)
Brain cancer (72)
Breast cancer (719)
Cancer (5562)
Cardiovascular disease (493)
Career advice (2660)
Career pathing (46)
CAR-T (323)
CDC (63)
Celiac Disease (2)
Cell therapy (879)
Cervical cancer (43)
Clinical research (75466)
Collaboration (2055)
Company closure (7)
Compensation (1225)
Complete response letters (86)
COVID-19 (2967)
CRISPR (109)
C-suite (1043)
Cystic fibrosis (159)
Data (7225)
Decentralized trials (3)
Denatured (74)
Depression (172)
Dermatology (58)
Diabetes (580)
Diagnostics (7252)
Digital health (53)
Diversity (13)
Diversity, equity & inclusion (44)
Drug discovery (333)
Drug pricing (220)
Drug shortages (31)
Duchenne muscular dystrophy (283)
Earnings (77833)
Editorial (68)
Employer branding (23)
Employer resources (163)
Events (121819)
Executive appointments (1104)
FDA (20514)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (14)
Frontotemporal dementia (30)
Funding (1711)
Gene editing (235)
Generative AI (67)
Gene therapy (728)
GLP-1 (1139)
Government (5290)
Grass and pollen (8)
Guidances (398)
Healthcare (20419)
HIV (77)
Huntington's disease (55)
IgA nephropathy (94)
Immunology and inflammation (310)
Immuno-oncology (88)
Indications (156)
Infectious disease (3304)
Inflammatory bowel disease (222)
Inflation Reduction Act (15)
Influenza (133)
Intellectual property (282)
Interviews (587)
IPO (16960)
IRA (52)
Job creations (4008)
Job search strategy (2200)
JPM (68)
Kidney cancer (20)
Labor market (95)
Layoffs (648)
Leadership (43)
Legal (7632)
Liver cancer (100)
Longevity (29)
Lung cancer (744)
Lymphoma (413)
Machine learning (54)
Management (64)
Manufacturing (956)
MASH (193)
Medical device (14442)
Medtech (14523)
Mergers & acquisitions (20553)
Metabolic disorders (1528)
mRNA (206)
Multiple sclerosis (181)
NASH (21)
Neurodegenerative disease (423)
Neuropsychiatric disorders (111)
Neuroscience (3375)
Neurotech (1)
NextGen: Class of 2026 (7215)
Non-profit (5081)
Now hiring (72)
Obesity (730)
Opinion (344)
Ovarian cancer (186)
Pain (242)
Pancreatic cancer (264)
Parkinson's disease (360)
Partnered (36)
Patents (567)
Patient recruitment (614)
Peanut (65)
People (64400)
Pharmaceutical (56)
Pharmacy benefit managers (33)
Phase 1 (23615)
Phase 2 (32987)
Phase 3 (24523)
Pipeline (7223)
Policy (341)
Postmarket research (3109)
Preclinical (10335)
Press Release (70)
Prostate cancer (286)
Psychedelics (58)
Radiopharmaceuticals (327)
Rare diseases (1089)
Real estate (6626)
Recruiting (77)
Regulatory (26442)
Reports (55)
Research institute (2727)
Resumes & cover letters (472)
Rett syndrome (33)
RNA editing (21)
RSV (89)
Schizophrenia (171)
Series A (291)
Series B (212)
Service/supplier (17)
Sickle cell disease (114)
Special edition (27)
Spinal muscular atrophy (181)
Sponsored (50)
Startups (3819)
State (2)
Stomach cancer (21)
Supply chain (120)
Tariffs (86)
The Weekly (96)
Vaccines (1182)
Venture capital (105)
Weight loss (480)
Women's health (112)
Worklife (23)
Date
Today (104)
Last 7 days (673)
Last 30 days (2879)
Last 365 days (31528)
2026 (8182)
2025 (31744)
2024 (36473)
2023 (41391)
2022 (52661)
2021 (57452)
2020 (56390)
2019 (49992)
2018 (38036)
2017 (34634)
2016 (34575)
2015 (40703)
2014 (33773)
2013 (29880)
2012 (31088)
2011 (31428)
2010 (30501)
Location
Africa (1065)
Alabama (95)
Alaska (7)
Arizona (310)
Arkansas (15)
Asia (45856)
Australia (8218)
California (12391)
Canada (3538)
China (1304)
Colorado (537)
Connecticut (540)
Delaware (371)
Europe (106545)
Florida (1840)
Georgia (409)
Hawaii (3)
Idaho (64)
Illinois (1035)
India (84)
Indiana (572)
Iowa (22)
Japan (500)
Kansas (133)
Kentucky (48)
Louisiana (41)
Maine (77)
Maryland (1492)
Massachusetts (8950)
Michigan (367)
Minnesota (646)
Mississippi (7)
Missouri (151)
Montana (37)
Nebraska (29)
Nevada (140)
New Hampshire (89)
New Jersey (3341)
New Mexico (32)
New York (3304)
North Carolina (1667)
North Dakota (10)
Northern California (6111)
Ohio (381)
Oklahoma (25)
Oregon (45)
Pennsylvania (2489)
Puerto Rico (26)
Rhode Island (50)
South America (1392)
South Carolina (72)
South Dakota (1)
Southern California (4860)
Tennessee (198)
Texas (1998)
United States (44335)
Utah (382)
Vermont (1)
Virginia (311)
Washington D.C. (86)
Washington State (1017)
West Virginia (4)
Wisconsin (137)
Wyoming (2)
775,735 Results for "association of clinical research organizations acro".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Rosalind Franklin University Innovation and Research Park Welcomes Clinical Research Organization’s Phase I/II Clinical Site
February 19, 2026
·
1 min read
IN PARTNERSHIP WITH TAKEDA
Takeda’s Commitment to Trial Representation is Shaping the Future of Clinical Research
One way Takeda lives out its values is by striving to ensure that patients are aware of and can access the company’s clinical trials. Two employees from its research and development organization discuss why representation matters and the work their team is doing to benefit patients now and in the future.
January 5, 2026
·
5 min read
·
BioSpace Insights
Press Releases
Tevogen Signs Letter of Intent to Evaluate Potential Acquisition of a Contract Research Organization
March 2, 2026
·
5 min read
Press Releases
Polaryx Therapeutics Selects Contract Research Organization for SOTERIA Phase 2 Basket Trial
February 17, 2026
·
6 min read
Press Releases
Revolution Medicines to Showcase Progress Across RAS(ON) Targeted Oncology Pipeline with Multiple Presentations at the 2026 American Association for Cancer Research (AACR) Annual Meeting
March 18, 2026
·
6 min read
Press Releases
Nurix Therapeutics Announces Multiple Presentations Showcasing Depth of Research Pipeline and Scientific Leadership at the American Association for Cancer Research (AACR) 2026 Annual Meeting
March 24, 2026
·
7 min read
Press Releases
Nuvectis Pharma Announces Upcoming Presentations for NXP900 at the 2026 American Association for Cancer Research Meeting
March 31, 2026
·
1 min read
Press Releases
SignaBlok to Present Novel Approach to Preventing Cancer Recurrence at the 2026 American Association for Cancer Research (AACR) Annual Meeting
Ligand-independent mechanism of action of SignaBlok’s first-in-class TREM-1 inhibitors enables development of cell-unspecific and macrophage-targeted TREM-1 inhibitors · In experimental pancreatic cancer, macrophage-targeted but not cell-unspecific TREM-1 inhibitor: − prevents cancer recurrence, improves complete response rate and survival, when administered in a time window of 7 days after standard-of-care (SOC) chemotherapy − reverses immunosuppression and overcomes cancer resistance to anti-PD-L1 immunotherapy · Timely resolution of acute inflammation induced by SOC cancer treatments (chemotherapy, surgery, radiation, radiopharmaceuticals, etc.) can be a common approach to prevent cancer recurrence, increase response rate and survival for not only pancreatic cancer but also other hard-to-treat tumors
March 26, 2026
·
1 min read
Press Releases
BBOT Announces Multiple Presentations at the American Association for Cancer Research (AACR) Annual Meeting 2026
March 18, 2026
·
2 min read
Press Releases
Context Therapeutics Announces Poster Presentation at the American Association for Cancer Research (AACR) Annual Meeting 2026
March 19, 2026
·
3 min read
1 of 77,574
Next